118 related articles for article (PubMed ID: 29032739)
1. Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.
Abdossamadi Z; Taheri T; Seyed N; Montakhab-Yeganeh H; Zahedifard F; Taslimi Y; Habibzadeh S; Gholami E; Gharibzadeh S; Rafati S
Immunotherapy; 2017 Oct; 9(13):1089-1102. PubMed ID: 29032739
[TBL] [Abstract][Full Text] [Related]
2. Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.
Abdossamadi Z; Seyed N; Zahedifard F; Taheri T; Taslimi Y; Montakhab-Yeganeh H; Badirzadeh A; Vasei M; Gharibzadeh S; Rafati S
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006123. PubMed ID: 29253854
[TBL] [Abstract][Full Text] [Related]
3. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
[TBL] [Abstract][Full Text] [Related]
4. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
[TBL] [Abstract][Full Text] [Related]
5. Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum.
Habibzadeh S; Doroud D; Taheri T; Seyed N; Rafati S
Iran Biomed J; 2021 Sep; 25(5):349-58. PubMed ID: 34481426
[TBL] [Abstract][Full Text] [Related]
6. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.
Badirzadeh A; Taheri T; Taslimi Y; Abdossamadi Z; Heidari-Kharaji M; Gholami E; Sedaghat B; Niyyati M; Rafati S
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005774. PubMed ID: 28708893
[TBL] [Abstract][Full Text] [Related]
7. F₁ cross-breed between susceptible BALB/c and resistant Swiss mice infected with Leishmania major exhibit an intermediate phenotype for lesion sizes and type 1 cytokines but show low level of total IgG antibodies.
Kiige SG; Mutiso JM; Laban LT; Khayeka-Wandabwa C; Anjili CO; Ingonga J; Gicheru MM
Scand J Immunol; 2014 May; 79(5):283-91. PubMed ID: 24498914
[TBL] [Abstract][Full Text] [Related]
8. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation.
Mehravaran A; Jaafari MR; Jalali SA; Khamesipour A; Tafaghodi M; Hojatizade M; Abbasi A; Badiee A
Iran J Immunol; 2015 Dec; 12(4):274-87. PubMed ID: 26714419
[TBL] [Abstract][Full Text] [Related]
9. Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.
Breton M; Tremblay MJ; Ouellette M; Papadopoulou B
Infect Immun; 2005 Oct; 73(10):6372-82. PubMed ID: 16177308
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
Mizbani A; Taheri T; Zahedifard F; Taslimi Y; Azizi H; Azadmanesh K; Papadopoulou B; Rafati S
Vaccine; 2009 Dec; 28(1):53-62. PubMed ID: 19818721
[TBL] [Abstract][Full Text] [Related]
11. In vitro leishmanicidal activity of antimicrobial peptide KDEL against Leishmania tarentolae.
Cao L; Jiang W; Cao S; Zhao P; Liu J; Dong H; Guo Y; Liu Q; Gong P
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1286-1292. PubMed ID: 31761925
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.
Bolhassani A; Taheri T; Taslimi Y; Zamanilui S; Zahedifard F; Seyed N; Torkashvand F; Vaziri B; Rafati S
Exp Parasitol; 2011 Mar; 127(3):637-45. PubMed ID: 21187086
[TBL] [Abstract][Full Text] [Related]
13. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
14. Prospects for antimicrobial peptide-based immunotherapy approaches in Leishmania control.
Zahedifard F; Rafati S
Expert Rev Anti Infect Ther; 2018 Jun; 16(6):461-469. PubMed ID: 29889579
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
16. Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection.
Suzue K; Kobayashi S; Takeuchi T; Suzuki M; Koyasu S
Int Immunol; 2008 Mar; 20(3):337-43. PubMed ID: 18195051
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice.
Von Stebut E; Ehrchen JM; Belkaid Y; Kostka SL; Molle K; Knop J; Sunderkotter C; Udey MC
J Exp Med; 2003 Jul; 198(2):191-9. PubMed ID: 12860932
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.
Salehi M; Taheri T; Mohit E; Zahedifard F; Seyed N; Taslimi Y; Sattari M; Bolhassani A; Rafati S
Immunotherapy; 2012 Nov; 4(11):1107-20. PubMed ID: 23194361
[TBL] [Abstract][Full Text] [Related]
20. Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.
Vilela Mde C; Gomes DC; Marques-da-Silva Ede A; Serafim TD; Afonso LC; Rezende SA
Acta Trop; 2007; 104(2-3):133-9. PubMed ID: 17919443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
